Precision Medicine Focus: Psychiatric Biomarkers

An interesting article was published today in the Journal of Precision Medicine describing the importance of testing psychiatry patients for mutations in two companion diagnostic biomarkers, CYP2D6 and CYP2C19. These are indeed important biomarkers for safe...

Chart of the Week: Value Network of Healthcare

We are mildly obssessed with our customers and the markets into which we sell BiomarkerBase™.  We have been thinking lately about the value chain in healthcare and have concluded that, like most industries, it’s quite complicated.  We have tried to represent the...

Dx Test Developers Experience Declining Revenue Growth

The news this week that CMS may reduce rates for some molecular diagnostic tests (by over 70% in a couple of cases) stimulated the idea of taking a quick look at the current market dynamics for diagnostic test developers. For this week’s post we decided to...